Cannabis: Difference between revisions
>Acetaminocetamol m Grammar fixes |
>MegurineLuka m tiny typo |
||
(9 intermediate revisions by 6 users not shown) | |||
Line 2: | Line 2: | ||
{{SubstanceBox/Cannabis}} | {{SubstanceBox/Cannabis}} | ||
'''Cannabis''' (also known as '''THC''', '''marijuana''',<ref name=" | '''Cannabis''' (also known as '''THC''',<ref name="wikithc">{{Citation | title=Definition of THC| url=https://wikipedia.org/wiki/Tetrahydrocannabinol}}</ref> '''marijuana''',<ref name="wikimarijuana">{{Citation | title=Definition of Marijuana | url=https://en.wikipedia.org/w/index.php?title=Marijuana_(word)&oldid=1097216058}}</ref> '''weed''',<ref name="merriamweed">{{Citation | title=Definition of Weed | url=https://www.merriam-webster.com/dictionary/weed}}</ref> '''pot''',<ref name="merriampot">{{Citation | title=Definition of POT | url=https://www.merriam-webster.com/dictionary/pot}}</ref> '''grass''',<ref name="merriamgrass">{{Citation | title=Definition of Grass | url=https://www.merriam-webster.com/dictionary/grass}}</ref> '''hemp''',<ref name="merriamhemp">{{Citation | title=Definition of HEMP | url=https://www.merriam-webster.com/dictionary/hemp}}</ref> '''zaza''',<ref name="urbanzaza">{{Citation | title=Definition of Zaza| url=https://www.urbandictionary.com/define.php?term=Zaza}}</ref> '''kush''',<ref name="urbankush">{{Citation | title=Definition of Kush| url=https://www.urbandictionary.com/define.php?term=Kush}}</ref> and many others) is a preparation of the cannabis plant that produces psychoactive effects when consumed (via [[smoking]], [[vaporizing]], or [[oral|ingestion]]). It is the most used illicit substance in the world.<ref name="ErowidCannabisVaultLegalStatus">{{Citation | title=Erowid Cannabis Vault : Legal Status | url=https://www.erowid.org/plants/cannabis/cannabis_law.shtml}}</ref><ref name="WDR-2010">{{Citation | title=WDR-2010 | url=//www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html}}</ref> The mechanism of action is [[agonist|binding activity]] at [[cannabinoid]] [[receptors]] distributed throughout the body.{{citation needed}} | ||
The principal psychoactive constituent of cannabis is tetrahydrocannabinol (THC), which makes up one of 483 known compounds in the plant,<ref>{{cite book | vauthors=((Russo, E. B.)) | date=5 September 2013 | title=Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential | publisher=Routledge | isbn=9781136614934}}</ref> including at least 84 other [[Chemical class::cannabinoid|cannabinoids]] such as [[cannabidiol]] (CBD), cannabinol (CBN), tetrahydrocannabivarin (THCV),<ref>{{cite journal | vauthors=((El-Alfy, A. T.)), ((Ivey, K.)), ((Robinson, K.)), ((Ahmed, S.)), ((Radwan, M.)), ((Slade, D.)), ((Khan, I.)), ((ElSohly, M.)), ((Ross, S.)) | journal=Pharmacology, biochemistry, and behavior | title=Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L | volume=95 | issue=4 | pages=434–442 | date= June 2010 | url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/ | issn=0091-3057 | doi=10.1016/j.pbb.2010.03.004}}</ref><ref>{{cite journal | vauthors=((Fusar-Poli, P.)), ((Crippa, J. A.)), ((Bhattacharyya, S.)), ((Borgwardt, S. J.)), ((Allen, P.)), ((Martin-Santos, R.)), ((Seal, M.)), ((Surguladze, S. A.)), ((O’Carrol, C.)), ((Atakan, Z.)), ((Zuardi, A. W.)), ((McGuire, P. K.)) | journal=Archives of General Psychiatry | title=Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing | volume=66 | issue=1 | pages=95 | date=1 January 2009 | url=https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482939 | issn=0003-990X | doi=10.1001/archgenpsychiatry.2008.519}}</ref> and cannabigerol (CBG). At least three species are recognized: ''Cannabis sativa'', ''Cannabis indica'', and ''Cannabis ruderalis''.{{citation needed}} | The principal psychoactive constituent of cannabis is tetrahydrocannabinol (THC), which makes up one of 483 known compounds in the plant,<ref>{{cite book | vauthors=((Russo, E. B.)) | date=5 September 2013 | title=Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential | publisher=Routledge | isbn=9781136614934}}</ref> including at least 84 other [[Chemical class::cannabinoid|cannabinoids]] such as [[cannabidiol]] (CBD), cannabinol (CBN), tetrahydrocannabivarin (THCV),<ref>{{cite journal | vauthors=((El-Alfy, A. T.)), ((Ivey, K.)), ((Robinson, K.)), ((Ahmed, S.)), ((Radwan, M.)), ((Slade, D.)), ((Khan, I.)), ((ElSohly, M.)), ((Ross, S.)) | journal=Pharmacology, biochemistry, and behavior | title=Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L | volume=95 | issue=4 | pages=434–442 | date= June 2010 | url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/ | issn=0091-3057 | doi=10.1016/j.pbb.2010.03.004}}</ref><ref>{{cite journal | vauthors=((Fusar-Poli, P.)), ((Crippa, J. A.)), ((Bhattacharyya, S.)), ((Borgwardt, S. J.)), ((Allen, P.)), ((Martin-Santos, R.)), ((Seal, M.)), ((Surguladze, S. A.)), ((O’Carrol, C.)), ((Atakan, Z.)), ((Zuardi, A. W.)), ((McGuire, P. K.)) | journal=Archives of General Psychiatry | title=Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing | volume=66 | issue=1 | pages=95 | date=1 January 2009 | url=https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482939 | issn=0003-990X | doi=10.1001/archgenpsychiatry.2008.519}}</ref> and cannabigerol (CBG). At least three species are recognized: ''Cannabis sativa'', ''Cannabis indica'', and ''Cannabis ruderalis''.{{citation needed}} | ||
Line 196: | Line 196: | ||
*Cannabinoid ratios: On average, ''Cannabis indica'' has higher levels of [[Tetrahydrocannabinol|THC]] compared to [[Cannabidiol|CBD]], whereas ''Cannabis sativa'' has lower levels of THC to CBD.<ref name="Hillig">{{cite journal |author1=Karl W. Hillig |author2=Paul G. Mahlberg |year=2004 |title=A chemotaxonomic analysis of cannabinoid variation in ''Cannabis'' (Cannabaceae) |journal=[[American Journal of Botany]] |volume=91 |issue=6 |pages=966–975 |pmid=21653452 |doi=10.3732/ajb.91.6.966|doi-access=free }}</ref> However, huge variability exists within either species. A 2015 study shows the average THC content of the most popular herbal cannabis products in the Netherlands has decreased slightly since 2005.<ref>{{cite journal |vauthors=Niesink RJ, Rigter S, Koeter MW, Brunt TM |title=Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15 |journal=Addiction |volume=110 |issue=12 |pages=1941–50 |year=2015 |doi=10.1111/add.13082 |pmid=26234170}}</ref> | *Cannabinoid ratios: On average, ''Cannabis indica'' has higher levels of [[Tetrahydrocannabinol|THC]] compared to [[Cannabidiol|CBD]], whereas ''Cannabis sativa'' has lower levels of THC to CBD.<ref name="Hillig">{{cite journal |author1=Karl W. Hillig |author2=Paul G. Mahlberg |year=2004 |title=A chemotaxonomic analysis of cannabinoid variation in ''Cannabis'' (Cannabaceae) |journal=[[American Journal of Botany]] |volume=91 |issue=6 |pages=966–975 |pmid=21653452 |doi=10.3732/ajb.91.6.966|doi-access=free }}</ref> However, huge variability exists within either species. A 2015 study shows the average THC content of the most popular herbal cannabis products in the Netherlands has decreased slightly since 2005.<ref>{{cite journal |vauthors=Niesink RJ, Rigter S, Koeter MW, Brunt TM |title=Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15 |journal=Addiction |volume=110 |issue=12 |pages=1941–50 |year=2015 |doi=10.1111/add.13082 |pmid=26234170}}</ref> | ||
*Terpene ratios: Sativa ancestry is associated with farnesene and | *Terpene ratios: Sativa ancestry is associated with farnesene and bergamotene, while Indica ancestry is associated with myrcene, elemene, and sesquiterpene alcohols. | ||
=====Criticism===== | =====Criticism===== | ||
Line 277: | Line 277: | ||
Individuals with a personal or family history of mental illness, particularly psychotic disorders like schizophrenia, should '''not''' use cannabis without the advice of a qualified mental health practitioner. | Individuals with a personal or family history of mental illness, particularly psychotic disorders like schizophrenia, should '''not''' use cannabis without the advice of a qualified mental health practitioner. | ||
===Trauma=== | |||
[https://en.wikipedia.org/wiki/Cannabis_use_and_trauma Cannabis use and trauma] are linked, with trauma playing a role in encouraging both the use and potential misuse of cannabis.<ref>{{cite journal | vauthors = Hyman SM, Sinha R | title = Stress-related factors in cannabis use and misuse: implications for prevention and treatment | journal = Journal of Substance Abuse Treatment | volume = 36 | issue = 4 | pages = 400–13 | date = June 2009 | pmid = 19004601 | doi = 10.1016/j.jsat.2008.08.005 | pmc = 2696937 }}</ref> Conversely, cannabis use has been associated with the intensity of trauma and PTSD symptoms.<ref name=":0">{{cite journal | vauthors = Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ | title = Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users | journal = Journal of Traumatic Stress | volume = 20 | issue = 4 | pages = 577–86 | date = August 2007 | pmid = 17721963 | doi = 10.1002/jts.20243 }}</ref><ref>{{cite journal | vauthors = Kevorkian S, Bonn-Miller MO, Belendiuk K, Carney DM, Roberson-Nay R, Berenz EC | title = Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample | journal = Psychology of Addictive Behaviors | volume = 29 | issue = 3 | pages = 633–8 | date = September 2015 | pmid = 26415060 | doi = 10.1037/adb0000110 | pmc = 4699174 }}</ref> While evidence of efficacious use of cannabis is growing in novelty, it is not currently recommended.<ref>{{cite journal | vauthors = Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L | display-authors = 6 | title = Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis | journal = The Lancet. Psychiatry | volume = 6 | issue = 12 | pages = 995–1010 | date = December 2019 | pmid = 31672337 | doi = 10.1016/s2215-0366(19)30401-8 | pmc = 6949116 }}</ref><ref>{{cite journal | vauthors = Dagan Y, Yager J | title = Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms | journal = The Journal of Nervous and Mental Disease | volume = 208 | issue = 8 | pages = 619–627 | date = August 2020 | pmid = 32433200 | doi = 10.1097/nmd.0000000000001172 | s2cid = 218766009 }}</ref> | |||
===Lethal dosage=== | ===Lethal dosage=== |